| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w19247 |
| 来源ID | Working Paper 19247 |
| Physician Agency and Competition: Evidence from a Major Change to Medicare Chemotherapy Reimbursement Policy | |
| Mireille Jacobson; Tom Y. Chang; Joseph P. Newhouse; Craig C. Earle, M.D. | |
| 发表日期 | 2013-07-25 |
| 出版年 | 2013 |
| 语种 | 英语 |
| 摘要 | We investigate the role of physician agency and competition in determining health care supply and patient outcomes. A 2005 change to Medicare fees had a large, negative impact on physician profit margins for providing chemotherapy treatment. In response to these cuts, physicians increased their provision of chemotherapy and changed the mix of chemotherapy drugs they administered. The increase in treatment improved patient survival. These changes were larger in states that experienced larger decreases in physician profit margins. Finally while physician response was larger in more competitive markets, survival improvements were larger in less competitive markets. |
| 主题 | Health, Education, and Welfare ; Health |
| URL | https://www.nber.org/papers/w19247 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/576922 |
| 推荐引用方式 GB/T 7714 | Mireille Jacobson,Tom Y. Chang,Joseph P. Newhouse,et al. Physician Agency and Competition: Evidence from a Major Change to Medicare Chemotherapy Reimbursement Policy. 2013. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
